Timing of stroke in elderly people exposed to typical and atypical antipsychotics: A replication cohort study after the paper of Kleijer, et al.

Journal of Psychopharmacology

Volumn 24, Issue 7, 2010, Pages 1131-1132

  Sacchetti, E ^a,b,c   Turrina, C ^a,b   Cesana, B ^a   Mazzaglia, G ^d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Brescia Spedali Civili ^*  (Italy)

^d Italian College of General Practitioners   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CEREBROVASCULAR DISEASE; HUMAN; INCIDENCE; LETTER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; HUMANS; LOGISTIC MODELS; RISK; STROKE;

EID: 77953780896     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109103202     Document Type: Letter

References (10)

1. Gill, SS, Rochon, PA, Herrmann, N., Lee, PE, Sykora, K., Gunray, N., et al. (2005) Atypical antipsychotic drugs and risk of ischemic stroke: population based retrospective cohort study. BMJ 330: 445.
2. Herrmann, N., Mamdani, M., Lanctot, KL (2004) Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161: 1113-1115.
3. Kleijer, BC, van Marum, RJ, Egberts, Acg, Jansen, Paf, Knol, W., Heerdink, ER (2008) Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacology. [epub July 17, 2008 ]
4. Leucht, S., Burkard, T., Henderson, J., Maj, M., Sartorius, N. (2007) Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 116: 317-333.
5. Miller, M. (2008) Management of physical health in schizophrenia: a stepping stone to treatment success. Eur Neuropsychopharm 18: S121 - S128.
6. Sacchetti, E., Trifiro, G., Caputi, A., Turrina, C., Spina, E., Cricelli, C., et al. (2008) Risk of stroke with typical and atypical antipsychotics: a retrospective cohort study including unexposed subjects. J Psychopharmacology 22: 39-46.
7. Schetz, JA, Perez, E., Liu, R., Chen, S., Lee, I., Simpkins, JW (2007) A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Res 1181: 1-9.
8. Yulug, B., Yildiz, A., Güzel, O., Kilic, E., Schäbitz, WR, Kilic, E. (2006 a) Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull 69: 656-659. (Pubitemid 43728750)
9. Yulug, B., Yildiz, A., Hüdaoglu, O., Kilic, E., Cam, E., Schäbitz, WR (2006 b) Olanzapine attenuates brain damage after focal cerebral ischemia in vivo. Brain Res 71: 296-300. (Pubitemid 44750446)
10. Yulug, B., Bakar, M., Ozan, E. (2008) The neuroprotective effect of olanzapine. J Neuropsychiatry Clin Neurosci 20: 107-108.